Prevalence, clinical manifestations, and immunology of herpesvirus infections in the acquired immunodeficiency syndrome.
D000163:Acquired Immunodeficiency Syndrome / Q000209:etiology / Q000276:immunology* / Q000382:microbiology / Q000503:physiopathology; D002460:Cell Line; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000150:complications / Q000276:immunology; D006564:Herpesviridae / Q000276:immunology / Q000302:isolation & purification; D006566:Herpesviridae Infections / Q000150:complications / Q000276:immunology*; D004854:Herpesvirus 4, Human / Q000276:immunology / Q000302:isolation & purification; D006716:Homosexuality; D006801:Humans; D007111:Immunity, Cellular; D007376:Interleukin-2 / Q000494:pharmacology; D007694:Killer Cells, Natural / Q000276:immunology; D008214:Lymphocytes / Q000187:drug effects; D008297:Male; D012306:Risk; D012514:Sarcoma, Kaposi / Q000150:complications / Q000276:immunology*
D007376:Interleukin-2